Shook, Lydia L.
Batorsky, Rebecca E.
De Guzman, Rose M.
McCrea, Liam T.
Brigida, Sara M.
Horng, Joy E.
Sheridan, Steven D.
Kholod, Olha
Cook, Aidan M.
Li, Jonathan Z.
Slonim, Donna K.
Goods, Brittany A.
Perlis, Roy H.
Edlow, Andrea G.
Funding for this research was provided by:
Eunice Kennedy Shriver National Institute of Child Health and Human Development (5K12HD103096, 1R01HD100022-01)
National Institutes of Health (5T32HG010464)
Massachusetts Consortium for Pathogen Readiness
National Institute of General Medical Sciences (P20GM130454)
National Institute of Mental Health (1RF1MH132336-01, 1RF1MH132336-01)
Article History
Received: 11 March 2024
Accepted: 18 June 2024
First Online: 25 June 2024
Declarations
:
: This study was approved by the Mass General Brigham Institutional Review Board (Protocol #2020P003538). All participants provided written informed consent prior to participation.
: Not applicable.
: R.H.P. has received fees for service as a scientific advisor to Belle Artificial Intelligence, Burrage Capital, Circular Genomics, Genomind, Swan Artificial Intelligence Studios, and Vault Health. A.G.E. serves as a consultant for Mirvie, Inc. and receives research funding from Merck Pharmaceuticals outside of this work. The other authors have no disclosures to report.